Skip to Main Content

Paper Details

H3K27me3 loss indicates an increased risk of recurrence in the Tübingen meningioma cohort.
Neuro Oncol
37
2021
Author NameAffiliation
Felix BehlingCenter for Neuro-Oncology, Comprehensive Cancer Center Tubingen-Stuttgart, University Hospital Tubingen, Eberhard Karls University Tubingen
Felix BehlingUniversity Hospital Tubingen, Eberhard Karls University Tubingen
Marco SkardellyCenter for Neuro-Oncology, Comprehensive Cancer Center Tubingen-Stuttgart, University Hospital Tubingen, Eberhard Karls University Tubingen
Marco SkardellyUniversity Hospital Tubingen, Eberhard Karls University Tubingen
Marcos TatagibaCenter for Neuro-Oncology, Comprehensive Cancer Center Tubingen-Stuttgart, University Hospital Tubingen, Eberhard Karls University Tubingen
Marcos TatagibaUniversity Hospital Tubingen, Eberhard Karls University Tubingen
Ghazaleh TabatabaiCenter for Neuro-Oncology, Comprehensive Cancer Center Tubingen-Stuttgart, University Hospital Tubingen, Eberhard Karls University Tubingen
Ghazaleh TabatabaiUniversity Hospital Tubingen, Eberhard Karls University Tubingen
Ghazaleh TabatabaiUniversity Hospital Tubingen, Hertie Institute for Clinical Brain Research, Eberhard Karls University Tubingen
Ghazaleh Tabatabai
Ghazaleh TabatabaiCluster of excellence (EXC 0) "Image Guided and Functionally Instructed Tumor Therapies," Eberhard Karls University Tubingen
  • 1 - 11

Datasets